Health

Drug companies to collaborate on Alzheimer's disease

The rising cost of development and research is making drug companies turn to each other for help. Rival companies that include Pfizer, AstraZeneca, and Roche plan on sharing clinical data in a standard format. But this isn't the first time we've seen pharmaceutical companies start to share data.

» Read more

0 Comments

Open pharmaceutical innovation

When it comes to infectious diseases, sharing is generally discouraged. But recently, pharmaceutical giant GlaxoSmithKline (GSK) opened up the designs behind 13,500 chemical compounds, which the company narrowed down from over two million, that may be capable of fighting malaria.

The process of determing which compounds could yield a malaria drug is time consuming and complex, but GSK hopes to inspire other researchers to pool their intellectual property and work together to develop new and better medicines to fight the diseases that are rampant in the world’s poorest countries. » Read more

1 Comment

Old phones save lives

Your old phone could make a big difference to a health worker in Africa.

IntraHealth International, a public health nonprofit, is launching a partnership with Hope Phones and FrontlineSMS:Medic to provide mobile phones to African health workers who offer maternal and child health services, including obstetric consultations, safe deliveries, family planning, and malaria and HIV prevention and treatment. » Read more

2 Comments

Open Thread Thursday: Patients like me

Check out patientslikeme.com. It's an online community that encourages you to share your healthcare experiences. And rather than a privacy policy, like most sites have, they have an "Openness Philosophy" page instead. You can view user comments on specific drugs or treatments that patients used for a variety of symptoms, illnesses and diseases. Communities exist for specific illnesses, like HIV/AIDs and Multiple Sclerosis. » Read more

4 Comments

Can open source save US health care?

With all the talk about health care in the United States, I decided to get the perspective of an entrepreneur focused on bringing open source to health care. I posed five questions to Matt Mattox, a friend and former Red Hatter, about the current state of US health care, but with an open source twist. Can open source save health care? Let's get Matt's take: » Read more

10 Comments

GlaxoSmithKline announces open innovation plans

Forbes reports that pharmaceutical giant GlaxoSmithKline announced a plan to beginning collaborating with other companies on research into drugs for diseases that don't get a lot of attention, malaria being a key example. It sounds like open innovation in action. Read the Forbes article here, but here's a key quote: » Read more

2 Comments